Heart Valve Repair

Heart Valve Repair

Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S. FDA to initiate the U.S. arm of its Tiara-I Early Feasibility Trial for the company's Tiara transcatheter mitral valve. The Tiara-I Early Feas...

September 22, 2014 — A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement (TAVR) can significantly reduce the number and volume of cerebral lesions in high-risk patients with severe...

Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new Medtronic CoreValve Evolut R System.

September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-expanding valve and 14 French equivalent delivery system offers new capabilities that advanc...

El Camino Hospital in Mountain View, California, became one of the first hospitals in California to adopt a new minimally invasive system to treat...
Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral valve insufficiency. The latter turned her life into a battle...
The U.S. Food and Drug Administration (FDA) approved the Sorin Freedom Solo and Solo Smart stentless heart valves from Sorin Group Canada Inc. to replace a...
Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart Aortic Pericardial Heart Valve. Faraz Kerendi, M.D. and Stephen J....
The Freedom Solo and Solo Smart stentless heart valves from Sorin Group Canada Inc. are designed to replace a diseased, damaged or
Philips Healthcare received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its precision planning application...
The Solo Smart Aortic Pericardial Heart Valve from Sorin Group is the first valve with a removable stent to be approved in the U.S. market...
The Edwards Sapien XT transcatheter aortic heart valve is indicated for the treatment of high-risk and inoperable patients suffering from...

Articles

Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S. FDA to initiate the U.S. arm of its Tiara-I Early...
October 10, 2014—Mitralign Inc. reported on the successful use of its technology to perform a percutaneous repair on a patient with tricuspid regurgitation (TR...
Emboline Prosheath
While transcatheter aortic valve replacement (TAVR) is a paradigm shift in how valve disease is treated, one nagging safety issue that remains is...
September 22, 2014 — A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement (TAVR) can...

Video Center

By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
4 weeks 6 days ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
8 weeks 1 day ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
13 weeks 6 days ago
This webinar will discuss why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...